학술논문

Safety and efficacy of a novel vaginal anti-infective, TOL-463, in the treatment of bacterial vaginosis and vulvovaginal candidiasis: A randomized, single-blind, phase 2, controlled trial
Document Type
Article
Source
In: Clinical Infectious Diseases. (Clinical Infectious Diseases, 15 February 2019, 68(5):803-809)
Subject
Language
English
ISSN
15376591
10584838